WHO Advances Malaria Battle with First Baby — Formulated Treatment & Enhanced Diagnostics. Dateline: Cotonou, Benin — April 25, 2026 The World Health Organization (WHO) has announced a significant advancement in the global fight against malaria, marking World Malaria Day with the prequalification of a pioneering treatment designed for the youngest malaria patients and the introduction of improved diagnostic tools.
The WHO’s prequalification of artemether-lumefantrine, marketed as Coartem Baby, marks the first malaria treatment specifically formulated for newborns and young infants, a move that promises to improve the treatment and safety of one of the most vulnerable patient groups. Until now, infants weighing between two and five kilograms had to be treated with formulations intended for older children, increasing the risk of dosing errors, adverse reactions, and toxicity.
In addition to the new treatment, the WHO has prequalified three new rapid diagnostic tests designed to overcome challenges with detecting certain malaria strains that have evolved resistance to current diagnostic tools. This innovation is critical in countries like those in the Horn of Africa, where up to 80% of malaria cases may go undiagnosed using traditional methods, leading to delayed treatment, severe illness, and death. These advancements come amidst the backdrop of a growing challenge in the global response to malaria, including drug resistance, insecticide resistance, diagnostic failures, and reduced international development assistance.
Despite these challenges, the WHO report on malaria for 2025 indicates substantial progress since 2000, with 2. 3 billion malaria infections prevented and 14 million lives saved. Dr.
Tedros Adhanom Ghebreyesus, WHO Director — General, emphasized the significance of these new tools: “Ending malaria in our lifetime is no longer a dream – it is a real possibility, but only with sustained political and financial commitment. Now we can. Now we must.”.
The introduction of Coartem Baby and the enhanced diagnostics represent a crucial step in the battle against malaria, especially for African countries burdened disproportionately by the disease.
As health organizations and NGOs commend the developments, concerns remain about distribution, sustainability, and the need for ongoing investment in research and treatment.
As the world celebrates the achievements and looks towards a future free of malaria, these innovations provide a glimmer of hope that, with collective efforts, the eradication of this deadly disease may indeed be within reach. Closing.
The prequalification of Coartem Baby and the new rapid diagnostic tests signify a turning point in the fight against malaria, offering new hope and a renewed focus on ending preventable child deaths from this disease. While the path forward remains complex, these developments underscore the importance of continued global cooperation and investment in malaria prevention, treatment, and research.
*Additional reporting by ImNews | Sources consulted: 5*
—
This original article was produced by the ImNews editorial team
Source: reliefweb
Source: World Health Organization
